e16252 Background: Within pathologically inflamed nonlymphoid tissues, T PH cells are uniquely positioned to stimulate B cell responses and antibody production. The phenotype, function and clinical relevance of T PH cells in hepatocellular carcinoma (HCC), however, are presently unknown. Methods: Flow cytometry was used to quantify the expression, phenotype and function of T PH cells. Log-rank tests were performed to evaluate disease-free survival and overall survival in samples from 39 patients and 101 patients with HCC. T PH cells, CD19 + B cells and T FH cells were cultured separately in vitro or isolated from C57/B6L mice in vivo for functional assays. Results: T PH cells highly infiltrated in tumor tissues, which influenced tumor sizes and early recurrence predictions and decreased survival times. The tumor-infiltrated T PH cells showed unique ICOS hi CXCL13 + IL-21 - MAF + BCL-6 - factors and triggered naïve B cell differentiation into regulatory B cells. Triggering PD-1 induced the production of CXCL13 by T PH cells, which then suppressed tumor-specific immunity and promoted disease progression. Conclusions: Our study reveals a novel regulatory mechanism of T PH cell-regulatory B cell mediated immunosuppression and provides an important perspective for the differentiation balance between protumorigenic T PH cells and antitumorigenic T FH cells in the HCC microenvironment.
No takes yet. Share an insight, caveat, or question.
Li et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: